Evidence map›Paper›PMID 26277085›Full record

ReviewCurrent opinion in microbiology2015

Taking a bite: Amoebic trogocytosis in Entamoeba histolytica and beyond.

Katherine S Ralston

Abstract readReview
In one paragraph

Review in Current opinion in microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Cross-species protection suggestsInfection and immunity · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Revisiting the Mechanisms of Immune Evasion Employed by Human Parasites.Frontiers in cellular and infection microbiology · 2021
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis.Frontiers in cellular and infection microbiology · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. From Toxoplasmosis to SchizophreniaFrontiers in psychiatry · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Katherine S RalstonDepartment of Microbiology and Molecular Genetics, University of California, Davis, USA. Electronic address: ksralston@ucdavis.edu.
University of California, Davis · US

Funding

"Biting" of human cells by Entamoeba histolytica: a novel cytotoxic mechanismK22AI108814 · NIAID · UNIVERSITY OF CALIFORNIA AT DAVIS · PI RALSTON, KATHERINE S · 2015 to 2016
$268k
NIAID NIH HHS 1K22AI108814NIAID NIH HHS K22 AI108814
6 · The paper itself

Abstract

Entamoeba histolytica is a diarrheal pathogen with the ability to cause profound host tissue damage. This organism possesses contact-dependent cell killing activity, which is likely to be a major contributor to tissue damage. E. histolytica trophozoites were recently shown to ingest fragments of living human cells. It was demonstrated that this process, termed amoebic trogocytosis, contributes to cell killing. Recent advances in ex vivo and 3-D cell culture approaches have shed light on mechanisms for tissue destruction by E. histolytica, allowing amoebic trogocytosis to be placed in the context of additional host and pathogen mediators of tissue damage. In addition to its relevance to pathogenesis of amoebiasis, an appreciation is emerging that intercellular nibbling occurs in many organisms, from protozoa to mammals.

Indexed as

AnimalsCell DeathEntamoeba histolyticaEntamoebiasisHost-Parasite InteractionsHumansIntestinesTrophozoites

Identifiers

PMID26277085
PMCPMC4542054
OpenAlexW1429227105

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.